Vytrus Biotech achieved +35% sales growth in 2024, surpassing €5.04M, with strong performance in the US, Europe (+34%), and Latin America (+231%). EBITDA rose 55% to...
Vytrus Biotech will present its Q3 2024 financials live on November 7, revealing record revenue of €4.6 million in the last year. Q3 sales rose by...
Vytrus Biotech reported a 28% sales increase in H1 2024, reaching €2.5 million, with EBITDA rising 38% to nearly €1 million. The growth was driven by...